Completed Grants

DatesPrincipal
Investigator(s)
Grant No./
Donor
Title
9/17-8/20Evan Unger, MD2R44CA144817-03Randomized Prospective Phase II Clinical Trial of NVX-108 in Association with Chemoradiation
6/12-4/17Ralph Mason, PhDRP120670-P3, CPRITEffects of Hypoxia: Project 3 in Exploiting the Radiobiology of Sterotactic Ablative Radiotherapy for Lung Cancer
12/14-11/17Kevin Pinney, Ph.D. (Baylor University)
Ralph Mason, PhD
RP 140399 CPRIT-IIRA; (Subcontract from Baylor University)Targeting Hypoxia in Breast Cancer with Highly Potent Small-Molecule Anticancer Prodrugs
8/14-8/17Ralph Mason, PhDRP140285, CPRITNoninvasive Identification of Prostate Tumor Hypoxia as a Prognostic Biomarker of Radiation Response
6/11-4/16Ralph Mason, PhDRP110441-C1, CPRITC1: In Vivo Imaging Core
8/10-7/15James K.V. Willson, M.D.P30 CA142543-01, NIH/NCICancer Center Support Grant
6/10-3/15Kevin G. Pinney, Ph.D. (Baylor University);
Ralph Mason, PhD
1 R01 CA140674-01, NIH/NCI; Subcontract with BaylorDiscovery and development of improved chemotherapeutic agents with enhanced selectivity for the tumor microenvironment
1/10-12/14Ralph Mason, PhDR01 CA139043-01A1, NIH/NCIHypoxia and radiotherapy: Evaluation and mitigation in tumors
4/07-3/13Ralph Mason, PhDU24CA126608A – SAIRP, NIH/NCIUT Southwestern Small Animal Imaging Resource
8/09-7/12Jian Yang, Ph.D.
(UT Arlington)
Ralph Mason, PhD
R21 EB009795-01, NIH/NIBIB;
(Subcontract with UT Arlington)
Enabling aliphatic biodegradable photoluminescent polymeric biomaterials
5/08-5/11Robert Timmerman, M.D.PC074348, USDODStereotactic body radiation therapy for underserved populations of men with low- and intermediate-risk prostate cancer.
4/09-3/11Philip Thorpe, Ph.D.PC081501, USDODTargeting phosphatidylserine to improve hormone therapy of prostate cancer
3/09-2/11Vikram D. Kodibagkar, Ph.D.1R21 CA132096-01A1; NIH, NCI1H MRI based nanosensors for imaging tumor oxygenation
4/07-11/10Ralph Mason, PhD1R21CA120774-01A1, NIH/NCIMAGIC – Magnetic Resonance Assessment of Gene Imaging Constructs
4/06-6/10Ralph Mason, PhDBC051255 – W81XWH-06-1-0475, DOD Breast Cancer Initiative: IDEA Development Award (no cost extension)Breast tumor detection and treatment using Tarvacin labeled with arsenic radionuclides
5/09-4/10Ralph Mason, PhD1S10RR02564801, ARRA-NIHSmall Animal Ultrasound System (VisualSonics Vevo 770)
8/07-2/10Ralph Mason, PhD081-07, The Mary Kay Ash Charitable FoundationPredicting treatment response for cervical cancer: Non-invasive assessment using bold MRI
9/05-12/09Ralph Mason, PhDPC050766 – W81XWH-06-1-0149, DOD Prostate Cancer Initiative: IDEA Development Award (IDA)Vatuximab™: Optimizing therapeutic strategies for prostate cancer based on dynamic MR tumor oximetry
9/07-9/08Ralph Mason, PhD1S10RR024757-01, NIH Shared Instrumentation GrantSmall animal bioluminescence and fluorescence imaging system (with 3D capability)
3/99-2/04Ralph Mason, PhDNIH 1R01 CA79515MR Measurement of tumor pH, pO2 and vascularity in vivo
5/01 – 4/04Ralph Mason, PhD1P20 CA086354NCI in vivo Cellular and Molecular Imaging Center (Pre-ICMIC)
10/99 – 9/02Ralph Mason, PhDDOD Breast Cancer Initiative BC980020 DAMD17-99-1-9381Breast tumor pH: design evaluation and application of novel reporter molecules
2000 – 2003Dr. Li LiuDOD BRCA IDEA grant  BC990287Non-invasive monitoring of breast tumor oxygenation: A key to tumor therapy planning and tumor prognosis
3/00-2/03Dr. Abbott; Mentor: Ralph Mason, PhDDOD Breast Cancer Initiative Predoctoral fellowship BC990911An Investigation of Breast Tumor Vasculature using Magnetic Resonance Microscopy
 Ralph Mason, PhD5-P41-RR02584 99-02NIH Biotechnology Research Technology program: service projects
5/01 – 4-03PI: Dawen Zhao, MD PhD; Mentor: Ralph Mason, PhD  Correlation of tumor oxygenation and angiogenesis: implications for therapy
9/89 – 8/90Ralph Mason, PhDInstitutional Research Grant from UT SouthwesternA non-invasive determination of oxygen tension in vivo: the use of 19F NMR spectroscopy to observe sequestered Fluosol-DA in the perfused heart
7/90 – 6/92Ralph Mason, PhDAmerican Heart Association (TX Affiliate) 90G-079A non-invasive assessment of myocardial oxygen tension
10/91 – 9/92Ralph Mason, PhDAmerican Cancer Society Grant IN-142: administered by UTSWGlutathione: non-invasive determination in the growing tumor
1/92 – 12/92Ralph Mason, PhDAccess Pharmaceuticals Inc.Unrestricted gift for Research & Development in MRI
7/92 – 6/93Ralph Mason, PhDAlliance Pharmaceutical CorporationOptimal exploitation of Oxygent to measure pO2 and temperature in vivo at 4.7 Tesla
7/93 – 6/96Ralph Mason, PhDAmerican Heart Association (TX Affiliate): 93G-082, Lyndon Baines Johnson Prize AwardeeA novel approach to measuring local myocardial oxygen tension
1/94 – 12/94Ralph Mason, PhDCambridge Isotopes LimitedProstate cancer: diagnosis using 1H DQCT and 13C NMR of citrate
7/96 – 10/96Ralph Mason, PhDNational Osteoporosis Foundation: student fellowshipBone structure/function relationship by MR microscopy and ultrasound elastometry
7/94 – 1/98Ralph Mason, PhDThe Whitaker FoundationInnovative approaches to tissue oximetry: 19F NMR of perfluorocarbons
4/98 – 3/99Ralph Mason, PhDThe Whitaker FoundationIntegrated Tissue Physiology by NMR
7/97-6/01Ralph Mason, PhDAmerican Cancer Society: RPG-97-116-010CCETumor Oximetry: mapping oxygenation dynamics by 19F magnetic resonance
10/97 – 6/01PI: Yulin Song PhD Mentor: Ralph Mason, PhDDepartment of Defense Breast Cancer Research Program: BC962357, DAMD17-97-1-7261
Student doctoral fellowship 1996
Non-invasive determination of breast cancer oxygen tension by F-19 NMR and Breast Cancer physiology in response to radiotherapy